6 Research on other GLP-1 related drugs Currently, research on the neuroprotective effects of GLP-1/GIP dual receptor agonists in PD is continuously advancing
If you were hoping it would also protect your bowel disease, the evidence does not currently support that expectation, and it should not factor into decisions about your IBD medications
How to get more fibre into your diet
If gastrointestinal side effects are intolerable despite optimal management, discontinuation may be appropriate, and your healthcare team can discuss alternative treatment options
Doctors found diabetes patients were losing weight, an unintended but beneficial result of the Ozempic regimen
Lazar V, Ditu LM, Pircalabioru GG, et al